Well there is only 2 weeks from today till we should hopefully get the new clinical data.
So before the news breaks, lets all have a guess/predict what the news will be.
My prediction is: a reduction in the spread of the disease via MRI scans compared to other assumed presentation without treatment, with a 30% reduction in symptoms (tremors). Including improved GIT symptoms as seen in the mice population during previous studies.
ATH434 drug levels reaching target levels within the brain as anticipated with no safety concerns.
Also a release on better symptom diagnosis for MSA specifically.
As to why I pulled out 30%, I think its a reasonable number given the short period of time.
ATH Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)